Beta Bionics, a medical technology company that develops and commercializes the world’s first fully automated bionic pancreas system, has announced that it has secured a manufacturing partner for its insulin delivery system. The company has partnered with Jabil Inc., a global manufacturing services company, to produce the iLet Bionic Pancreas System.<\/p>\n
The iLet Bionic Pancreas System is a fully automated insulin delivery system that uses artificial intelligence to continuously monitor glucose levels and deliver the appropriate amount of insulin to the patient. The system is designed to improve the lives of people with type 1 diabetes by reducing the burden of managing their condition and improving their overall health outcomes.<\/p>\n
The partnership with Jabil will allow Beta Bionics to scale up production of the iLet Bionic Pancreas System and bring it to market more quickly. Jabil has extensive experience in manufacturing medical devices and will provide Beta Bionics with the expertise and resources needed to produce the iLet Bionic Pancreas System at scale.<\/p>\n
“We are thrilled to partner with Jabil to manufacture the iLet Bionic Pancreas System,” said Ed Damiano, CEO and co-founder of Beta Bionics. “Jabil’s expertise in medical device manufacturing will be invaluable as we work to bring this life-changing technology to people with type 1 diabetes.”<\/p>\n
The iLet Bionic Pancreas System has already undergone successful clinical trials, demonstrating its safety and efficacy in managing glucose levels in people with type 1 diabetes. The system is expected to receive regulatory approval in the United States in 2022.<\/p>\n
The partnership with Jabil is a significant milestone for Beta Bionics as it moves closer to bringing the iLet Bionic Pancreas System to market. The company is committed to improving the lives of people with type 1 diabetes and believes that the iLet Bionic Pancreas System has the potential to revolutionize diabetes management.<\/p>\n
In conclusion, Beta Bionics’ partnership with Jabil is a positive development for the company and for people with type 1 diabetes. The iLet Bionic Pancreas System has the potential to transform diabetes management and improve the lives of millions of people around the world. With Jabil’s manufacturing expertise, Beta Bionics is well-positioned to bring this life-changing technology to market and make a meaningful impact on the lives of people with type 1 diabetes.<\/p>\n
Beta Bionics, a medical technology company that develops and commercializes the world’s first fully automated bionic pancreas system, has announced that it has secured a manufacturing partner for its insulin delivery system. The company has partnered with Jabil Inc., a global manufacturing services company, to produce the iLet Bionic Pancreas System. The iLet Bionic Pancreas […]<\/p>\n","protected":false},"author":2,"featured_media":2527037,"menu_order":0,"template":"Default","format":"standard","meta":[],"aiwire-tag":[1147,11,342,1150,2150,18,343,2158,5806,20,2162,5976,569,570,21,790,571,23,443,1160,29436,2549,793,7149,29,966,2000,9457,6242,1321,972,222,2336,6709,11555,4262,4828,4315,38,867,10021,7107,2921,12630,10788,9465,2195,163,1788,3233,743,50,1513,1222,4230,168,169,1800,57,1987,608,5768,60,61,62,2226,12907,394,178,614,753,1804,1852,68,6936,396,7606,19553,18798,5189,2740,2961,69,11583,1065,75,78,5454,262,2103,4336,1261,489,545,5,10,7,8,81,82,1921,831,190,89,1359,2110,1100,5838,669,268,496,706,1112,357,2986,4566,1114,99,1959,102,781,204,108,109,360,110,9604,111,3135,9487,426,18840,1960,1961,844,211,9,124,125,1305,362,6],"aiwire":[23161],"_links":{"self":[{"href":"https:\/\/platoai.gbaglobal.org\/wp-json\/wp\/v2\/platowire\/2543785"}],"collection":[{"href":"https:\/\/platoai.gbaglobal.org\/wp-json\/wp\/v2\/platowire"}],"about":[{"href":"https:\/\/platoai.gbaglobal.org\/wp-json\/wp\/v2\/types\/platowire"}],"author":[{"embeddable":true,"href":"https:\/\/platoai.gbaglobal.org\/wp-json\/wp\/v2\/users\/2"}],"version-history":[{"count":0,"href":"https:\/\/platoai.gbaglobal.org\/wp-json\/wp\/v2\/platowire\/2543785\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/platoai.gbaglobal.org\/wp-json\/wp\/v2\/media\/2527037"}],"wp:attachment":[{"href":"https:\/\/platoai.gbaglobal.org\/wp-json\/wp\/v2\/media?parent=2543785"}],"wp:term":[{"taxonomy":"aiwire-tag","embeddable":true,"href":"https:\/\/platoai.gbaglobal.org\/wp-json\/wp\/v2\/aiwire-tag?post=2543785"},{"taxonomy":"aiwire","embeddable":true,"href":"https:\/\/platoai.gbaglobal.org\/wp-json\/wp\/v2\/aiwire?post=2543785"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}